WCP
BSX icon

Wick Capital Partners’s Boston Scientific BSX Stock Holding History

Wick Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$275K Buy
+4,387
New +$351K 0.05% 163

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wick Capital Partners's BSX Position: Q1 2026 in Review

Wick Capital Partners opened a new position in Boston Scientific (BSX) in Q1 2026: 4,387 shares worth $275K. The stake represents 0.05% of the portfolio and ranks #163 among its holdings.

1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Wick Capital Partners held 4,387 shares of Boston Scientific worth $275K as of Q1 2026.
  • Boston Scientific was a new Wick Capital Partners position in Q1 2026.
  • Boston Scientific made up 0.05% of Wick Capital Partners's portfolio in Q1 2026, its #163 holding.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Wick Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.